Research Reports
Gram Positive Bacterial Sepsis Diagnosis to Acquire Major Momentum : Report Fact.MR
Published by top news
Posted on August 11, 2021
Global Banking and Finance Review
Company
Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Published by top news
Posted on August 11, 2021
Fact.MR’s revised sepsis diagnostics market study forecasts a healthy growth trajectory for FY 2021-22 and beyond, with the market expected to increase at a CAGR worth around 8% through 2031. Growth prospects were further underpinned amidst the coronavirus pandemic, attributed to the onset of pneumonia-induced sepsis and consequent fatalities.
According to the report, the market is expected to yield high short-term gains, generating over US$ 700 million in revenue by 2026. These are largely attributed to ongoing research & development initiatives amid a general upswing in ICU and hospital admission-induced sepsis amongst patients. Manufacturers are incorporating the latest automated technologies to ensure precision and timely diagnostics.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=391
Epidemiologically, an estimated 22 cases of childhood sepsis per 100,000 person-years and 2,202 cases of neonatal sepsis per 100,000 live births occur. This translates into 1.2 million cases of childhood sepsis annually. Most recent estimates attributed an adult prevalence rate of 19.4 million sepsis incidences, with over 5 million deaths. Hence, investments are underway to introduce highly sophisticated sepsis diagnostic approaches, which are expected to incline demand over the coming years.
“As the frequency of hospital admissions for various diseases increases, risk of developing sepsis during treatment is rising, prompting healthcare settings to incorporate sepsis diagnostics and detection systems, spurring heightened R&D to introduce new solutions,” comments a Fact.MR analyst.
Have a Query? Connect to Research Analyst https://www.factmr.com/connectus/sample?flag=AE&rep_id=391
| Product Type |
|
| Method |
|
| Pathogen |
|
| Technology |
|
Full Access of this Report Is Available At https://www.factmr.com/checkout/391
The global sepsis diagnostics market is interspersed with the presence of a large number of diagnostic service providers, rendering it highly competitive in nature. Amongst all the expansion strategies deployed, offering technologically advanced solutions by virtue of conducting immense R&D remains the core objective.
For More Insights https://www.accesswire.com/641064/Personal-Flotation-Devices-Sales-to-Improve-with-Increasing-Demand-for-Water-Sports-Recreational-Activities-FactMR
Fact.MR, in its new offering, presents an unbiased analysis of the sepsis diagnostics market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (blood culture media, instruments, and assays & reagents), method (conventional diagnostics and automated diagnostics), pathogen (gram-negative bacterial species, gram-positive bacterial species, fungal species, and other pathogens), and technology (microbiology, molecular diagnostics, immunoassays and other technologies), across six major regions of the world (North America, Latin America, Europe, APEJ, Japan, and MEA).
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Fact.MR’s revised sepsis diagnostics market study forecasts a healthy growth trajectory for FY 2021-22 and beyond, with the market expected to increase at a CAGR worth around 8% through 2031. Growth prospects were further underpinned amidst the coronavirus pandemic, attributed to the onset of pneumonia-induced sepsis and consequent fatalities.
According to the report, the market is expected to yield high short-term gains, generating over US$ 700 million in revenue by 2026. These are largely attributed to ongoing research & development initiatives amid a general upswing in ICU and hospital admission-induced sepsis amongst patients. Manufacturers are incorporating the latest automated technologies to ensure precision and timely diagnostics.
To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=391
Epidemiologically, an estimated 22 cases of childhood sepsis per 100,000 person-years and 2,202 cases of neonatal sepsis per 100,000 live births occur. This translates into 1.2 million cases of childhood sepsis annually. Most recent estimates attributed an adult prevalence rate of 19.4 million sepsis incidences, with over 5 million deaths. Hence, investments are underway to introduce highly sophisticated sepsis diagnostic approaches, which are expected to incline demand over the coming years.
“As the frequency of hospital admissions for various diseases increases, risk of developing sepsis during treatment is rising, prompting healthcare settings to incorporate sepsis diagnostics and detection systems, spurring heightened R&D to introduce new solutions,” comments a Fact.MR analyst.
Have a Query? Connect to Research Analyst https://www.factmr.com/connectus/sample?flag=AE&rep_id=391
| Product Type |
|
| Method |
|
| Pathogen |
|
| Technology |
|
Full Access of this Report Is Available At https://www.factmr.com/checkout/391
The global sepsis diagnostics market is interspersed with the presence of a large number of diagnostic service providers, rendering it highly competitive in nature. Amongst all the expansion strategies deployed, offering technologically advanced solutions by virtue of conducting immense R&D remains the core objective.
For More Insights https://www.accesswire.com/641064/Personal-Flotation-Devices-Sales-to-Improve-with-Increasing-Demand-for-Water-Sports-Recreational-Activities-FactMR
Fact.MR, in its new offering, presents an unbiased analysis of the sepsis diagnostics market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of product (blood culture media, instruments, and assays & reagents), method (conventional diagnostics and automated diagnostics), pathogen (gram-negative bacterial species, gram-positive bacterial species, fungal species, and other pathogens), and technology (microbiology, molecular diagnostics, immunoassays and other technologies), across six major regions of the world (North America, Latin America, Europe, APEJ, Japan, and MEA).
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact: